myirislogo
23 November, 2014 15:04 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 305.05 2.68
Hindalco In 160.15 3.42
Bhel 252.75 3.00
Tata Stl 462.70 0.89
Tata Motors 530.45 1.11
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Venus Remedies Limited
Venus Remedies Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:526953NSE:VENUSREMBloomberg:VNR@INReuters:VENR.BO
Market Lot: 1Face Value: 10ISIN Demat: INE411B01019
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
12-NOV-14 Venus Remedies, a research based pharmaceutical company, has achieves yet another landmark by receiving marketing authorization in Switzerland through its German subsidiary Venus Pharma GmbH from Swiss drug authority (SWISSMEDIC) for its generic product Meropenem 500 mg & 1 g injection. 25-SEP-14 Venus Remedies has entered Singapore's topical pain management market with a marketing authorisation and patent for its herbal nanotechnolo...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Venus in talks to market Trois in Singapore  -IRIS 25-Sep-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 1208.135186.904590.97
Other Income1.004.063.95
Total Income1209.135190.964594.92
Cost of goods sold918.413928.273428.50
OPBDIT290.721262.691166.42
PAT102.49609.50571.45
Gross Block---
Equity capital114.42114.42105.42
EPS (Rs.)-54.1954.21
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-2.58 - 6.612.91 - 6.05
Debt / Equity (x)---
Operating margin (% of OI)24.024.325.4
Net margin (% of OI) 8.511.712.4
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
SCO 857
Cabin No 10
IInd Floor
NAC Manimajra
Chandigarh
Union Territory-160 101
PHONE
- - -
FAX
- - -
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer